Healthcare UK

British Technology company, C the Signs, selected by the White House-Backed Accelerator Programme, CancerX, to half Cancer Deaths

Retrieved on: 
Mardi, février 27, 2024
Cancer Moonshot, AstraZeneca, Intel, Atrium Health, National Health Service, Quality of life, Hope, White, Risk, Social work, NHS, Health care, UC, Business, Patient, Accelerator, Dell Technologies, NHS England, Disease, Heart, Healthcare UK, Mortality, AWS, Cancer, Pharmaceutical industry

CancerX was unveiled by the White House in a landmark announcement last year to spearhead innovation in oncology.

Key Points: 
  • CancerX was unveiled by the White House in a landmark announcement last year to spearhead innovation in oncology.
  • The CancerX Accelerator programme aims to promote and fortify digital innovations in oncology by providing promising startups an opportunity to collaborate with leading cancer organizations.
  • C the Signs is an AI cancer prediction platform that identifies patients at risk of cancer at the earliest and most curable stage of the disease.
  • Launched by the White House, this initiative marks a significant step toward realizing the Cancer Moonshot's vision of a 50% reduction in cancer mortality.

British Technology company, C the Signs, selected by the White House-Backed Accelerator Programme, CancerX, to half Cancer Deaths

Retrieved on: 
Mardi, février 27, 2024
Cancer Moonshot, AstraZeneca, Intel, Atrium Health, National Health Service, Quality of life, Hope, White, Risk, Social work, NHS, Health care, UC, Business, Patient, Accelerator, Dell Technologies, NHS England, Disease, Heart, Healthcare UK, Mortality, AWS, Cancer, Pharmaceutical industry

CancerX was unveiled by the White House in a landmark announcement last year to spearhead innovation in oncology.

Key Points: 
  • CancerX was unveiled by the White House in a landmark announcement last year to spearhead innovation in oncology.
  • The CancerX Accelerator programme aims to promote and fortify digital innovations in oncology by providing promising startups an opportunity to collaborate with leading cancer organizations.
  • C the Signs is an AI cancer prediction platform that identifies patients at risk of cancer at the earliest and most curable stage of the disease.
  • Launched by the White House, this initiative marks a significant step toward realizing the Cancer Moonshot's vision of a 50% reduction in cancer mortality.